145020Hugel145020 info
$191.85info2.62%24h
Global rank8658
Market cap$836.13M
Change 7d2.00%
YTD Performance71.96%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Business data

    Hugel (145020) Stock Overview

    Hugel, Inc. operates as a biopharmaceutical company in South Korea and internationally. It offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults aged between 18 and 65; treatment of upper limb stroke; and treatment of dynamic equinus foot deformity in children with cerebral palsy over 2 years of age, as well as improvement of external angles of secondary ideals related to orbicularis oculi muscle activity in adults aged between 19 and 65 under the Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot brands. The company also provides hyaluronic acid filler under the Dermalax, Hyalsense, Revigance, and The Chaeum brand names; cosmetics under the Wellage brand; and medical devices. Hugel, Inc. was founded in 2001 and is headquartered in Chuncheon-si, South Korea.

    145020 Stock Information

    Symbol
    145020
    Address
    61-20, Sinbuk-roChuncheon-si, 24206South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.hugel.co.kr
    Country
    🇰🇷 South Korea
    Phone Number
    82 3 3255 3882

    Hugel (145020) Price Chart

    -
    Value:-

    Hugel Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $191.85
    N/A
    Market Cap
    $836.13M
    N/A
    Shares Outstanding
    4.36M
    N/A
    Employees
    562.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org